Sensitive and reproducible liquid chromatography-tandem mass spectrometry method for quantification of sibutramine in human plasma

Forensic Toxicology

Volumn 25, Issue 1, 2007, Pages 30-36

  Nirogi, Ramakrishna V S ^a   Kandikere, Vishwottam ^a   Shukla, Manoj ^a   Mudigonda, Koteshwara ^a   Maurya, Santosh ^a  

^a SUVEN LIFE SCIENCES LTD   (India)

Author keywords

Citalopram; High performance liquid chromatography; Human plasma; Sibutramine; Tandem mass spectrometry

Indexed keywords

CITALOPRAM; SIBUTRAMINE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; STANDARD; TANDEM MASS SPECTROMETRY;

EID: 34249783481     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-007-0024-8     Document Type: Article

References (13)

1. Luque CA, Rey JA (2002) The discovery and status of sibutramine as an anti-obesity drug. Eur J Pharmacol 440:119-128
2. The World Anti-Doping Code (2006) The 2006 prohibited list international standard. World Anti-Doping Agency, Montreal. www.wada-ama.org. Cited 4 Jan 2007
3. McNeely W, Goa KL (1998) Sibutramine: a review of its contribution to the management of obesity. Drugs 56:1093-1124
4. Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S (2006) Quantification of tizanidine in human plasma by liquid chromatography coupled to tandem mass spectrometry. Rapid Commun Mass Spectrom 20:2286-2292. DOI 10.1002/rcm.2592
5. Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Boosi R (2006) Quantification of clopidogrel in human plasma by sensitive liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 20:1695-1700. DOI 10.1002/rcm.2497
6. Jain DS, Subbaiah G, Sanyal M, Shrivastav PS, Pal U, Ghataliya S, Kakad A, Patel H, Shah S (2006) Liquid chromatography/electrospray ionization tandem mass spectrometry validated method for the simultaneous quantification of sibutramine and its primary and secondary amine metabolites in human plasma and its application to a bioequivalence study. Rapid Commun Mass Spectrom 20:3509-3521. DOI 10.1002/rcm.2760
7. Abolfathi Z, Couture J, Vallee F, LeBel M, Tanguay M, Masson E (2004) A pilot study to evaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions. J Pharm Pharm Sci 7:345-349
8. Chen J, Lu W, Zhang Q, Jiang X (2003) Determination of the active metabolite of sibutramine by liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr B 785:197-203
9. Thevis M, Sigmund G, Schiffer AK, Schanzer W (2006) Determination of N-desmethyl-and N-bisdesmethyl metabolites of sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry. Eur J Mass Spectrom 12:129-136
10. Ding L, Hao X, Huang X, Zhang S (2003) Simultaneous determination of sibutramine and its N-desmethyl metabolites in human plasma by liquid chromatography-electrospray ionization-mass spectrometry method and clinical applications. Anal Chim Acta 492:241-248
11. Strano-Rossi S, Colamonici C, Botre F (2007) Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites. Rapid Commun Mass Spectrom 21:79-88. DOI 10.1002/rcm.2807
12. Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75:3019-3030
13. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Vishwanathan CT, Cook CE, McDowall RD (1991) Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur J Drug Metab Pharmacokinet 16:249-255